Literature DB >> 18268167

Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.

P Michael Ho1, David J Magid, Susan M Shetterly, Kari L Olson, Pamela N Peterson, Frederick A Masoudi, John S Rumsfeld.   

Abstract

BACKGROUND: Despite the importance of blood pressure (BP) control in secondary prevention, a significant proportion of patients with coronary disease have uncontrolled BP.
METHODS: This retrospective cohort study of patients with coronary disease (N = 10 447) evaluated the impact of medication nonadherence and therapy intensification on reaching target BP goals. Medication adherence was calculated as the proportion of days covered for filled prescriptions of antihypertensive medications. Therapy intensification included dosage increase or increase in number of antihypertensive medications. The primary outcome was uncontrolled systolic BP (SBP) over time, using a latent class model that incorporated longitudinal SBP data and assigned patients to SBP trajectory groups. Multivariable regression evaluated the association between medication nonadherence (ie, proportion of days covered, <0.80) and therapy intensification with SBP control over time, with adjustment for demographics and clinical characteristics.
RESULTS: Three SBP trajectory groups were identified: (1) patients with BP that remained controlled (ie, SBP, <or=140 mm Hg) over time (n = 9114 [87.2%]); (2) patients with high BP that became controlled (n = 779 [7.5%]); and (3) patients with BP that remained high over time (n = 554 [5.3%]). In multivariable analyses, therapy intensification (odds ratio, 1.31; 95% confidence interval, 1.01-1.70) and medication nonadherence (odds ratio, 1.73; 95% confidence interval, 1.34-2.24) were associated with uncontrolled BP compared with high SBP that became controlled over time.
CONCLUSIONS: These findings suggest that medication nonadherence can help explain why BP levels remained elevated despite intensification of antihypertensive medications. Successful BP control is seen with a combination of intensification and adherence, suggesting that therapy intensification must be coupled with interventions to enhance medication adherence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18268167     DOI: 10.1001/archinternmed.2007.72

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  54 in total

1.  Medication non-adherence after myocardial infarction: an exploration of modifying factors.

Authors:  Matthew J Crowley; Leah L Zullig; Bimal R Shah; Ryan J Shaw; Jennifer H Lindquist; Eric D Peterson; Hayden B Bosworth
Journal:  J Gen Intern Med       Date:  2015-01       Impact factor: 5.128

2.  How patient cost-sharing trends affect adherence and outcomes: a literature review.

Authors:  Michael T Eaddy; Christopher L Cook; Ken O'Day; Steven P Burch; C Ron Cantrell
Journal:  P T       Date:  2012-01

3.  Kidney disease and antihypertensive medication adherence: the need for improved measurement tools.

Authors:  Tara I Chang; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2010-09       Impact factor: 8.860

4.  Interventions aimed at improving performance on medication adherence metrics.

Authors:  Brandy McGinnis; Yardlee Kauffman; Kari L Olson; Daniel M Witt; Marsha A Raebel
Journal:  Int J Clin Pharm       Date:  2014-02

5.  Are two commonly used self-report questionnaires useful for identifying antihypertensive medication nonadherence?

Authors:  Benjamin D Gallagher; Paul Muntner; Nathalie Moise; Jenny J Lin; Ian M Kronish
Journal:  J Hypertens       Date:  2015-05       Impact factor: 4.844

6.  A Qualitative Study of Older Adults and Computer Use for Health Education: "It opens people's eyes"

Authors:  Jessica Alicea-Planas; Patricia J Neafsey; Elizabeth Anderson
Journal:  J Commun Healthc       Date:  2011-04-01

7.  Hypertension in Ireland: public awareness and doctors choice of therapy.

Authors:  N L Zaharan; A Mahmud; K Bennett; J Feely
Journal:  Ir J Med Sci       Date:  2009-10-17       Impact factor: 1.568

8.  Reducing adverse self-medication behaviors in older adults with the Next Generation Personal Education Program (PEP-NG): Design and methodology.

Authors:  Patricia J Neafsey; Elizabeth Anderson; Craig Coleman; Carolyn A Lin; Cyr E M'lan; Stephen Walsh
Journal:  Patient Prefer Adherence       Date:  2009-11-29       Impact factor: 2.711

9.  Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?

Authors:  Richard H Chapman; Elise M Pelletier; Paula J Smith; Craig S Roberts
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

10.  A pilot program at the worksite to reduce adverse self-medication behaviors.

Authors:  Patricia J Neafsey; Gregory Lutkus; Jessica Newcomb; Elizabeth Anderson
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.